Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dinesh Raghu

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Molecular & Cellular Proteomics : MCP|February 22, 2018
Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer CellsTwishi Gulati, Cheng Huang, Franco Caramia, et al.
Oncotarget|May 7, 2017
E6AP promotes prostate cancer by reducing p27 expressionDinesh Raghu, Piotr Jan Paul, Twishi Gulati, et al.
The Journal of Pathology|January 19, 2017
MDM4 is a rational target for treating breast cancers with mutant p53Panimaya Jeffreena Miranda, Daniel Buckley, Dinesh Raghu, et al.
Cancers|August 26, 2022
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 StatusJavier Octavio Mejía-Hernández, Dinesh Raghu, Franco Caramia, et al.
Science Immunology|October 6, 2023
TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinomaMarina H Yakou, Sonia Ghilas, Kelly Tran, et al.
The Journal of Experimental Medicine|May 31, 2019
TCF-1 limits the formation of Tc17 cells via repression of the MAF-RORγt axisLisa A Mielke, Yang Liao, Ella Bridie Clemens, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Molecular & Cellular Proteomics : MCP|February 22, 2018
Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer CellsTwishi Gulati, Cheng Huang, Franco Caramia, et al.
Oncotarget|May 7, 2017
E6AP promotes prostate cancer by reducing p27 expressionDinesh Raghu, Piotr Jan Paul, Twishi Gulati, et al.
The Journal of Pathology|January 19, 2017
MDM4 is a rational target for treating breast cancers with mutant p53Panimaya Jeffreena Miranda, Daniel Buckley, Dinesh Raghu, et al.
Cancers|August 26, 2022
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 StatusJavier Octavio Mejía-Hernández, Dinesh Raghu, Franco Caramia, et al.
Science Immunology|October 6, 2023
TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinomaMarina H Yakou, Sonia Ghilas, Kelly Tran, et al.
The Journal of Experimental Medicine|May 31, 2019
TCF-1 limits the formation of Tc17 cells via repression of the MAF-RORγt axisLisa A Mielke, Yang Liao, Ella Bridie Clemens, et al.
Pageof 2